Holen Sie sich die Stockscreener-App
1.31
2.96%
-0.04
Schlusskurs vom Vortag:
$1.35
Offen:
$1.35
24-Stunden-Volumen:
68,422
Relative Volume:
0.04
Marktkapitalisierung:
$11.76M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-2.4717
EPS:
-0.53
Netto-Cashflow:
$-22.36M
1W Leistung:
-0.76%
1M Leistung:
-3.68%
6M Leistung:
-21.08%
1J Leistung:
-72.93%
1-Tages-Spanne:
$1.28
$1.35
1-Wochen-Bereich:
$1.28
$1.36
52-Wochen-Spanne:
$0.95
$5.695
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.31 | 11.76M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Is Evogene Ltd. a good long term investmentRemarkable growth - PrintWeekIndia
Evogene Ltd. Stock Analysis and ForecastExplosive earning power - PrintWeekIndia
What drives Evogene Ltd. stock priceExceptional trading results - PrintWeekIndia
How Evogene Ltd. stock reacts to Fed policy changesRecord-setting profit potential - jammulinksnews.com
What analysts say about Evogene Ltd. stockRemarkably fast returns - jammulinksnews.com
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - global-agriculture.com
How Evogene Ltd. stock compares to its top competitorsIs SBCF stock undervalued or overvalued nowFree Daily Stock Market Updates - Newser
Evogene Updates Proxy Card for August 2025 Shareholder Meeting - TipRanks
Why Evogene Ltd. stock attracts strong analyst attentionMulti Bagger Alerts - beatles.ru
What makes Evogene Ltd. stock price move sharplyHigh Return Potential - Newser
How Evogene Ltd. stock performs during market volatilityChart Based Entries - Newser
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital - global-agriculture.com
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer - global-agriculture.com
Evogene Completes Sale of Lavie Bio’s Activities to ICL - The Globe and Mail
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activity to ICL - global-agriculture.com
ICL Finalizes Acquisition of AI-Driven Ag Tech Company Lavie Bio - AgriBusiness Global
EVGN closes Lavie Bio sale to ICL; financial terms undisclosed | UHG SEC FilingForm 8-K - Stock Titan
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL - PR Newswire
Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences - Yahoo Finance
Evgn - AInvest
Evogene to Receive $3.5 million Payment Related to Patent Portfolio under its Existing Seed Traits Collaboration with Bayer - global-agriculture.com
Evogene Schedules First Quarter 2025 Financial Results Release - global-agriculture.com
Evogene Announces Annual General Meeting for August 2025 - TipRanks
Citadel Advisors LLC Makes New Investment in Evogene Ltd. (NASDAQ:EVGN) - Defense World
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud - MSN
Cannabis Stocks To Keep An Eye On – June 10th - Defense World
Evogene, Google Cloud innovation to revolutionise ag-chemicals - Far Eastern Agriculture
Evogene Becomes Talk Of Retail Town As Stock Doubles On Genai Drug, Agri Discovery Model With Google Cloud - MENAFN.com
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):